220 related articles for article (PubMed ID: 29929514)
1. Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.
Henriques G; Phommasone K; Tripura R; Peto TJ; Raut S; Snethlage C; Sambo I; Sanann N; Nguon C; Adhikari B; Pongvongsa T; Imwong M; von Seidlein L; Day NP; White NJ; Dondorp AM; Newton P; Ley B; Mayxay M
Malar J; 2018 Jun; 17(1):243. PubMed ID: 29929514
[TBL] [Abstract][Full Text] [Related]
2. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
Roca-Feltrer A; Khim N; Kim S; Chy S; Canier L; Kerleguer A; Tor P; Chuor CM; Kheng S; Siv S; Kachur PS; Taylor WR; Hwang J; Menard D
PLoS One; 2014; 9(12):e116143. PubMed ID: 25541721
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M
Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.
Wojnarski B; Lon C; Sea D; Sok S; Sriwichai S; Chann S; Hom S; Boonchan T; Ly S; Sok C; Nou S; Oung P; Kong N; Pheap V; Thay K; Dao V; Kuntawunginn W; Feldman M; Gosi P; Buathong N; Ittiverakul M; Uthaimongkol N; Huy R; Spring M; Lek D; Smith P; Fukuda MM; Wojnarski M
PLoS One; 2020; 15(1):e0228207. PubMed ID: 32004348
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
Satyagraha AW; Sadhewa A; Elvira R; Elyazar I; Feriandika D; Antonjaya U; Oyong D; Subekti D; Rozi IE; Domingo GJ; Harahap AR; Baird JK
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004457. PubMed ID: 26894297
[TBL] [Abstract][Full Text] [Related]
6. Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection.
Abdul-Ghani R; Mahdy MA; Saif-Ali R; Alkubati SA; Alqubaty AR; Al-Mikhlafy AA; Al-Eryani SM; Al-Mekhlafi AM; Alhaj A
Malar J; 2016 Jun; 15():327. PubMed ID: 27329471
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for asymptomatic malaria and genotyping of glucose 6-phosphate (G6PD) deficiencies in a vivax-predominant setting, Lao PDR: implications for sub-national elimination goals.
Lover AA; Dantzer E; Hongvanthong B; Chindavongsa K; Welty S; Reza T; Khim N; Menard D; Bennett A
Malar J; 2018 Jun; 17(1):218. PubMed ID: 29859089
[TBL] [Abstract][Full Text] [Related]
8. Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
Roh ME; Oyet C; Orikiriza P; Wade M; Mwanga-Amumpaire J; Boum Y; Kiwanuka GN; Parikh S
Am J Trop Med Hyg; 2016 Nov; 95(5):1094-1099. PubMed ID: 27672207
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines.
Espino FE; Bibit JA; Sornillo JB; Tan A; von Seidlein L; Ley B
PLoS One; 2016; 11(2):e0148172. PubMed ID: 26849445
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion.
Bancone G; Menard D; Khim N; Kim S; Canier L; Nguong C; Phommasone K; Mayxay M; Dittrich S; Vongsouvath M; Fievet N; Le Hesran JY; Briand V; Keomany S; Newton PN; Gorsawun G; Tardy K; Chu CS; Rattanapalroj O; Dong LT; Quang HH; Tam-Uyen N; Thuy-Nhien N; Hien TT; Kalnoky M; Nosten F
Malar J; 2019 Jan; 18(1):20. PubMed ID: 30674319
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd), CareStart qualitative rapid diagnostic test performance, and genetic variants in two malaria-endemic areas in Sudan.
Ali Albsheer MM; Lover AA; Eltom SB; Omereltinai L; Mohamed N; Muneer MS; Mohamad AO; Abdel Hamid MM
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009720. PubMed ID: 34699526
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a point-of-care diagnostic to identify glucose-6-phosphate dehydrogenase deficiency in Brazil.
Zobrist S; Brito M; Garbin E; Monteiro WM; Clementino Freitas S; Macedo M; Soares Moura A; Advani N; Kahn M; Pal S; Gerth-Guyette E; Bansil P; Domingo GJ; Pereira D; Lacerda MV
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009649. PubMed ID: 34383774
[TBL] [Abstract][Full Text] [Related]
13. Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
Ley B; Winasti Satyagraha A; Rahmat H; von Fricken ME; Douglas NM; Pfeffer DA; Espino F; von Seidlein L; Henriques G; Oo NN; Menard D; Parikh S; Bancone G; Karahalios A; Price RN
PLoS Med; 2019 Dec; 16(12):e1002992. PubMed ID: 31834890
[TBL] [Abstract][Full Text] [Related]
14. The challenges of introducing routine G6PD testing into radical cure: a workshop report.
Ley B; Luter N; Espino FE; Devine A; Kalnoky M; Lubell Y; Thriemer K; Baird JK; Poirot E; Conan N; Kheong CC; Dysoley L; Khan WA; Dion-Berboso AG; Bancone G; Hwang J; Kumar R; Price RN; von Seidlein L; Domingo GJ
Malar J; 2015 Sep; 14():377. PubMed ID: 26416229
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa.
Adu-Gyasi D; Asante KP; Newton S; Dosoo D; Amoako S; Adjei G; Amoako N; Ankrah L; Tchum SK; Mahama E; Agyemang V; Kayan K; Owusu-Agyei S
PLoS One; 2015; 10(4):e0125796. PubMed ID: 25885097
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of G6PD diagnostic test for Plasmodium vivax radical cure in Lao PDR: An economic modelling study.
Aung YN; Tun STT; Vanisaveth V; Chindavongsa K; Kanya L
PLoS One; 2022; 17(4):e0267193. PubMed ID: 35468145
[TBL] [Abstract][Full Text] [Related]
17. Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
Kim S; Nguon C; Guillard B; Duong S; Chy S; Sum S; Nhem S; Bouchier C; Tichit M; Christophel E; Taylor WR; Baird JK; Menard D
PLoS One; 2011; 6(12):e28357. PubMed ID: 22164279
[TBL] [Abstract][Full Text] [Related]
18. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.
Brito MA; Peixoto HM; Almeida AC; Oliveira MR; Romero GA; Moura-Neto JP; Singh N; Monteiro WM; Lacerda MV
Rev Soc Bras Med Trop; 2016; 49(4):446-55. PubMed ID: 27598631
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
Taylor WRJ; Kim S; Kheng S; Muth S; Tor P; Christophel E; Mukaka M; Kerleguer A; Luzzatto L; Baird JK; Menard D
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009690. PubMed ID: 34495956
[TBL] [Abstract][Full Text] [Related]
20. Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
Oo NN; Bancone G; Maw LZ; Chowwiwat N; Bansil P; Domingo GJ; Htun MM; Thant KZ; Htut Y; Nosten F
PLoS One; 2016; 11(4):e0152304. PubMed ID: 27035821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
